Chloratet 50 description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Chloratet 50

ADM Alliance Nutrition, Inc.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

CHLORATET™ 50 (CHLORTETRACYCLINE)
TYPE A MEDICATED ARTICLE GRANULAR

ACTIVE DRUG INGREDIENT

Chlortetracycline Calcium Complex Equivalent to 50 g/lb. Chlortetracycline HCl/lb.

INGREDIENTS

Dried Streptomyces Aureofaciens Fermentation Product, Calcium Carbonate, and Mineral Oil.

Purpose

FOR MANUFACTURE OF DRY FEED ONLY

DIRECTIONS FOR USE

Uses

Chickens - (Broiler/Fryer):

DOSAGE LEVEL INDICATIONS FOR USE
10-50 g/t For an increased rate of weight gain and improved feed efficiency
100-200 g/t Control of infectious synovitis caused by Mycoplasma synoviae susceptible to chlortetracycline. (Feed continuously for 7 to 14 days)
200-400 g/t Control of chronic respiratory disease (CRD) and air sac infection caused by Mycoplasma gallisepticum and Escherichia coli susceptible to chlortetracycline. (Feed continuously for 7 to 14 days).

WARNING: Do not feed to chickens producing eggs for human consumption.

Uses

DOSAGE LEVEL INDICATIONS FOR USE
500 g/t Reduction of mortality due to Escherichia coli infections susceptible to chlortetracycline (Feed for 5 days).

WARNING: Do not feed to chickens producing eggs for human consumption. Withdraw 24 hours prior to slaughter.

Uses

Growing Turkeys:

DOSAGE LEVEL INDICATIONS FOR USE
10-50 g/t For an increased rate of weight gain and improved feed efficiency.

Uses

Turkeys:

DOSAGE LEVEL INDICATIONS FOR USE
200 g/t Control of infectious synovitis caused by Mycoplasma synoviae susceptible to chlortetracycline (Feed continuously for 7 to 14 days)
400 g/t Control of hexamitiasis caused by Hexamita meleagridis susceptible to chlortetracycline. (Feed continuously for 7 to 14 days).
Turkey poults not over 4 weeks of age: Reduction of mortality due to paratyphoid caused by Salmonella typhimurium susceptible to chlortetracycline.
25 mg/pound body weight daily Control of complicating bacterial organisms associated with bluecomb (transmissible enteritis, coronaviral enteritis) susceptible to chlortetracycline. (Feed continuously for 7 to 14 days)

WARNING: Do not feed to turkeys producing eggs for human consumption.

Uses

Growing Swine:

DOSAGE LEVEL INDICATIONS FOR USE
10-50 g/t For an increased rate of weight gain and improved feed efficiency.

Swine:

DOSAGE LEVEL INDICATIONS FOR USE
50-100 g/t Reducing the incidence of cervical lymphadenitis (jowl abscesses) caused by Group E Streptococci susceptible to chlortetracycline.

Breeding Swine:

DOSAGE LEVEL INDICATIONS FOR USE
400 g/t Control of leptospirosis (reducing the instances of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to chlortetracycline. (Feed continuously for not more than 14 days).

Uses

Swine:

DOSAGE LEVEL INDICATIONS FOR USE
10 mg/lb. body weight daily Treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline. (Feed for not more than 14 days. Feed approximately 400 g/ton, varying with body weight and feed consumption to provide 10 mg/lb body weight per day.)

WARNING: Five-day withdrawal period

Uses

Calves:

DOSAGE LEVEL INDICATIONS FOR USE
0.1 mg/lb. body weight daily Calves (up to 250 lbs.): For an increased rate of body weight gain and improved feed efficiency.
25-70 mg/head/day Calves (250-400 lbs.) For an increased rate of weight gain and improved feed efficiency

Uses

Growing Cattle:

DOSAGE LEVEL INDICATIONS FOR USE
70 mg/head/day Growing cattle (over 400 lbs.): For an increased rate of weight gain, improved feed efficiency and reduction of liver condemnation due to liver abscesses.
Zero-Day Withdrawal Period

WARNING: A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to be processed for veal.

Uses

Beef Cattle:

DOSAGE LEVEL INDICATIONS FOR USE
350 mg/head/day For the control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline.
350 mg/head/day Beef cattle (under 700 lbs.): Control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline.
0.5 mg/lb. daily Beef cattle (over 700 lbs.): control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline.

WARNING: Withdraw 48 hours prior to slaughter.

Uses

For calves, beef and non-lactating dairy cattle:

DOSAGE LEVEL INDICATIONS FOR USE
10 mg/lb. body weight daily Treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline. (Treat for not more than 5 days. Feed approximately 400 g/ton, varying with body weight and feed consumption to provide 10 mg/lb body weight per day. )

WARNING: Withdraw 10 days prior to slaughter. A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to be processed for veal.

NADA 48-480

ADM Alliance Nutrition, Inc.
Quincy, IL 62305-3115

70165014
NET WEIGHT 50 POUNDS (22.67 kg)
19008WH

PRINCIPAL DISPLAY PANEL - 22.67 kg Bag Label

CHLORATET™
50
(Chlortetracycline)

Type A Medicated Article Granular

Active Drug Ingredient
Chlortetracycline Calcium Complex
Equivalent to 50 g/lb. Chlortetracycline HCl/Ib.
NADA 48-480, Approved by FDA

NET WT 50 LB (22.67 kg)

Chloratet 50

Chloratet 50

Chlortetracycline Hydrochloride GRANULE

Product Information

Product Type Otc type a medicated article animal drug label Item Code (Source) NDC:12286-009
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
Chlortetracycline Hydrochloride CHLORTETRACYCLINE 50 g

Inactive Ingredients

Ingredient Name Strength
CALCIUM CARBONATE
Mineral Oil

Product Characteristics

Color
GRAY

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:12286-009-01 22.67 in 1 BAG

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NADA NADA048480 2007-02-01


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.